The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children

Sponsor
Vilnius University (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT05287074
Collaborator
(none)
200
1
83
2.4

Study Details

Study Description

Brief Summary

The aim of this study is to gain more knowledge on the nutritional and immunological aspects of allergy to milk and eggs in children.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Food allergy in children is an emerging problem in many countries. Milk and eggs are important sources of nutrition in childhood. Restricting these products in children's diets can affect the quality of child's life and nutrition, which is paramount to good physical and mental child development during this vulnerable period of life. The aim of this study is to gain more knowledge on the nutritional and immunological aspects of immunoglobulin E (IgE) mediated allergy to milk and eggs in children. In this study we will analyze parent perceived child's quality of life, factual nutrition (assessed by 3-day food diaries), food allergy self efficacy measure for parents, parent perceived quality of life will be assessed using Food Allergy Quality of Life Questionnaire - Parent Form, anthropometric measures of children (height and weight), serum nutritional markers (vitamin D, calcium, magnesium, iron and phosphorous), sensitization tests (specific Immunoglobulin E (sIgE) to milk and egg and their components) as well as markers of allergic inflammation (interleukin 10, 13, 17, 25 and 33, eosinophil count and serum Immunoglobulin E). Food allergy will be confirmed by an oral food challenge (OFC), variables will be compared between different OFC outcomes (sensitized-allergic/sensitized-non-allergic).

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    200 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    The Significance of a Timely Food Allergy Diagnosis and Optimal Surveillance of Nutritional Status in Children
    Actual Study Start Date :
    Jul 1, 2021
    Anticipated Primary Completion Date :
    Jul 1, 2023
    Anticipated Study Completion Date :
    Jun 1, 2028

    Outcome Measures

    Primary Outcome Measures

    1. Evaluation of the daily food intake of children following egg and/or milk elimination diets. [Within one month of enrolment.]

      Dietary intake will be assessed by a 3-day food diary, the nutrient intake will be analyzed using national food composition database and a nutritional analysis software.

    2. Antropometric measurements - Z-scores [Within one day of enrolment.]

      Anthropometric measurements (weight and height) will be recorded and evaluated as Z-scores using the WHO ANTHRO program and WHO ANTHRO Plus Software.

    Secondary Outcome Measures

    1. Evaluation of parental confidence in managing food allergy. [Within one month of enrollment]

      Parental confidence will be assessed using Food Allergy Self-Efficacy Scale for Parents (FASE-P), (scale of 0 to 100).

    2. Evaluation of the parent perceived quality of life of children following egg and/or milk elimination diets. [Within one month of enrollment]

      Parent perceived quality of life will be assessed using Food Allergy Quality of Life Questionnaire - Parent Form (FAQLQ-PF), (scale of 0 to 6).

    Other Outcome Measures

    1. Prick to Prick test with cow's milk mean value. [Within one month of enrollment]

      Prick to Prick test with cow's milk mean value.

    2. Prick to Prick test with hen's egg mean value. [Within one month of enrollment]

      Prick to Prick test with hen's egg mean value.

    3. Measurement of serum total IgE. [Within one month of enrollment]

      Measurement of serum total IgE.

    4. Measurement of serum eosinophils. [Within one month of enrollment]

      Measurement of serum eosinophils

    5. Measurement of serum specific IgE to milk extract. [Within one month of enrollment]

      Measurement of serum specific IgE to milk extract.

    6. Measurement of serum specific IgE to egg extract. [Within one month of enrollment]

      Measurement of serum specific IgE to egg extract.

    7. Measurement of serum specific IgE to casein. [Within one month of enrollment]

      Measurement of serum specific IgE to casein.

    8. Measurement of serum specific IgE to betalactoglobulin. [Within one month of enrollment]

      Measurement of serum specific IgE to betalactoglobulin.

    9. Measurement of serum specific IgE to ovomucoid. [Within one month of enrollment]

      Measurement of serum specific IgE to ovomucoid.

    10. Measurement of serum specific IgE to ovalbumin. [Within one month of enrollment]

      Measurement of serum specific IgE to ovalbumin.

    11. Laboratory measurement of vitamin D concentration. [Within one month of enrollment]

      Laboratory measurement of vitamin D concentration.

    12. Laboratory measurement of serum calcium concentration. [Within one month of enrollment]

      Laboratory measurement of serum calcium concentration.

    13. Laboratory measurement of serum phosphorus concentration. [Within one month of enrollment]

      Laboratory measurement of serum phosphorus concentration.

    14. Laboratory measurement of serum iron concentration. [Within one month of enrollment]

      Laboratory measurement of serum iron concentration.

    15. Laboratory measurement of serum magnesium concentration. [Within one month of enrollment]

      Laboratory measurement of serum magnesium concentration.

    16. Laboratory measurement of serum interleukin 25. [Within one month of enrollment]

      Laboratory measurement of serum interleukin 25.

    17. Laboratory measurement of serum interleukin 33. [Within one month of enrollment]

      Laboratory measurement of serum interleukin 33.

    18. Laboratory measurement of serum interleukin 17. [Within one month of enrollment]

      Laboratory measurement of serum interleukin 17.

    19. Laboratory measurement of serum interleukin 13. [Within one month of enrollment]

      Laboratory measurement of serum interleukin 13.

    20. Laboratory measurement of serum interleukin 10. [Within one month of enrollment]

      Laboratory measurement of serum interleukin 10.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Months to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Subjects from 6 months to 12 years of age and their parents / guardians.

    • Subjects with suspected or confirmed allergy to chicken's egg and/or cow's milk. Suspected food allergy is defined as sensitization to a food that has not been consumed recently (in the last 3 months) without symptoms or sensitization to a food that has never been consumed. A confirmed food allergy is defined as a food allergy that has previously been confirmed by a positive result of an oral food challenge.

    • Legal guardians of the subject are capable to sign a written informed consent form.

    Exclusion Criteria:
    • Subjects to whom food allergies are unlikely (who have recently eaten a suspected food without symptoms or who have not eaten food recently but have never had symptoms and are not sensitized).

    • Subjects to whom an oral food challenge is contraindicated.

    • Subjects with comorbid chronic diseases affecting the child 's nutrition and growth.

    • Legal guardians of the subject do not wish to participate in the study or are unable to sign a written consent form.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vilnius University Hospital Santaros Clinics Vilnius Lithuania

    Sponsors and Collaborators

    • Vilnius University

    Investigators

    • Principal Investigator: Ieva Adomaite, MD, Vilnius University Faculty of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vilnius University
    ClinicalTrials.gov Identifier:
    NCT05287074
    Other Study ID Numbers:
    • MAMS2018
    First Posted:
    Mar 18, 2022
    Last Update Posted:
    Mar 18, 2022
    Last Verified:
    Jul 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Vilnius University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 18, 2022